Rochester, Minn.-based Mayo Clinic is partnering with biotech company Naveris to launch a clinical trial of the company’s precision medicine blood test for tumor tissue DNA, NavDx.
Rochester, Minn.-based Mayo Clinic is partnering with biotech company Naveris to launch a clinical trial of the company’s precision medicine blood test for tumor tissue DNA, NavDx.